Clinical Trials Directory

Trials / Completed

CompletedNCT02846714

Family Lifestyle Actions and Risk Education Study

FLARE: Family Lifestyle Actions and Risk Education Study for Children With a Familial Risk for Melanoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
University of Utah · Academic / Other
Sex
All
Age
8 Years – 110 Years
Healthy volunteers
Not accepted

Summary

The overall purpose of this study is to test the feasibility, acceptability, and preliminary efficacy of a family-focused behavioral intervention ("FLARE", which stands for Family Lifestyle Actions and Risk Education) that aims to improve adherence to melanoma preventive behaviors among children at elevated risk for the disease.

Detailed description

Test the feasibility and acceptability of FLARE, a family-focused behavioral intervention that is designed to improve and maintain adherence to photoprotection (e.g., use of sunscreen) and screening (e.g., implementation of self skin exams). We expect that the feasibility of the intervention will be supported by at least 75% of participants attending at least 3 intervention sessions. We also expect that the acceptability of the intervention (e.g., overall satisfaction, ease of participation, perceived utility of intervention) will be supported by mean ratings that indicate adequate levels of acceptability across participants (e.g., mean rating of "satisfied" or "very satisfied" for overall satisfaction). Pilot test the efficacy of the FLARE intervention with children at elevated risk for melanoma and their primary caregiver. We will also explore the potential impact of the FLARE intervention on melanoma preventive behaviors among siblings of the child who receives the intervention, as well as the child's other parent/caregiver (if another parent/caregiver is available).

Conditions

Interventions

TypeNameDescription
BEHAVIORALFLARE

Timeline

Start date
2016-07-01
Primary completion
2017-11-01
Completion
2017-11-01
First posted
2016-07-27
Last updated
2019-05-08
Results posted
2019-05-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02846714. Inclusion in this directory is not an endorsement.